ALEXION PHARMACEUTICALS, INC. 4/A SEC Filings

Filed On	Filing
30 Jun 2015	Form 4/A: Baker Felix, Director and 5 others Received 6,835,569 shares as a grant or award
28 Oct 2014	Form 4/A: Moriarty John B, SVP & General Counsel Disposed of 10,000 shares (Option Exercise/Conversion) ($927K)
15 Jun 2011	Form 4/A: Norby R Douglas, Director Granted 2,786 Option to Purchase Common Stock
15 Jun 2011	Form 4/A: Parven Alvin S, Director Granted 2,786 Option to Purchase Common Stock
15 Jun 2011	Form 4/A: Madri Joseph A, Director Granted 2,786 Option to Purchase Common Stock
25 Feb 2011	Form 4/A: Link Max, Director Acquired 0 shares (Other Transaction)
29 Dec 2010	Form 4/A: Hallal David, SVP Commercial Ops, Americas Received 2,500 shares by exercise or conversion ($40.8K) · Disposed of 2,500 Option to Purchase Common Stock (Open Market Sale)
09 Nov 2010	Form 4/A: Hallal David, SVP Commercial Ops, Americas Sold 2,619 shares ($184K) · Received 20,000 shares by exercise or conversion ($326K) · Sold 20,000 shares ($1.45M) · 1 more
14 Feb 2006	Form 4/A: Mojcik Christopher F, SVP Clinical Development Received 5,000 shares as a grant or award ($104K) · Granted 12,000 Option to Purchase Common Stock, par value $.0001
29 Jun 2005	Form 4/A: Boess Carsten, Former CFO Received 11,250 shares by exercise or conversion ($263K) · Sold 6,250 shares ($146K)
12 Apr 2005	Form 4/A: Bowdish Katherine S, Senior Vice President Received 13,000 shares as a grant or award · Granted 10,000 Option to Purchase Common Stock, par value $.0001
12 Apr 2005	Form 4/A: Dubin Thomas I H, VP & General Counsel Received 13,000 shares as a grant or award · Granted 10,000 Option to Purchase Common Stock, par value $.0001
12 Apr 2005	Form 4/A: Luke Barry P, VP Finance & Administration Received 1,500 shares as a grant or award · Granted 3,000 Option to Purchase Common Stock, par value $.0001

Comments